Table 3:
Adverse Effects Leading to Therapy Adjustment
Ganciclovir (n=52) | Foscarnet (n=12) | P Value | |
---|---|---|---|
Filgrastim Use | |||
# of Patients (%) | 28 (54%) | 9 (75%) | 0.21 |
Median # of Doses (Range) | 1 (0 to 23) | 4 (0 to 25) | 0.27 |
Dialysis | |||
# of Patients (%) | 0 (0%) | 3 (25%) | <0.05 |
Median # of Days (Range) | - | 36 (1 to 79) | - |
Total # of Days | - | 116 | - |
# of Days per Patient | - | 9.7 | - |